Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Adynxx, Inc. (ADYX)
OTHER OTC:ADYX
Holding ADYX?
Track your performance easily
ADYX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range― - ―
Previous Close$0.02
Volume27.00
Average Volume (3M)N/A
Market Cap
$6.00
Enterprise Value$9.15M
Total Cash (Recent Filing)$331.00K
Total Debt (Recent Filing)$9.48M
Price to Earnings (P/E)―
Beta-0.17
Next Earnings
Nov 14, 2019EPS EstimateN/A
Last Dividend Ex-Date
May 06, 2019Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume3
30 Day Avg. VolumeN/A
Standard Deviation0.63
R-Squared0.04
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)0.09
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue15.54
Enterprise Value/Gross Profit18.45
Enterprise Value/Ebitda-1.54
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ADYX FAQ
What was Adynxx, Inc.’s price range in the past 12 months?
Currently, no data Available
What is Adynxx, Inc.’s market cap?
Currently, no data Available
When is Adynxx, Inc.’s upcoming earnings report date?
Adynxx, Inc.’s upcoming earnings report date is Nov 14, 2019 which is 1772 days ago.
How were Adynxx, Inc.’s earnings last quarter?
Adynxx, Inc. released its earnings results on Aug 14, 2019. The company reported -$0.87 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.87.
Is Adynxx, Inc. overvalued?
According to Wall Street analysts Adynxx, Inc.’s price is currently Overvalued.
Does Adynxx, Inc. pay dividends?
Adynxx, Inc. pays a Notavailable dividend of $1.05 which represents an annual dividend yield of N/A. See more information on Adynxx, Inc. dividends here
What is Adynxx, Inc.’s EPS estimate?
Adynxx, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Adynxx, Inc. have?
Adynxx, Inc. has 5,808,000 shares outstanding.
What happened to Adynxx, Inc.’s price movement after its last earnings report?
Adynxx, Inc. reported an EPS of -$0.87 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Adynxx, Inc.?
Currently, no hedge funds are holding shares in ADYX
---
Company Description
Adynxx, Inc.
Adynxx, Inc. is a clinical stage biopharmaceutical company. It engages in the manufacture, development, and sale of novel, disease-modifying products for the treatment of pain and inflammation. The company was founded by Julien Mamet in October 2007 and is headquartered in San Francisco, CA.
---
---